The pandemic exacerbated clinician burnout and labor shortages as providers added more digital demands to the daily workflow. Doctors generally embrace technology to help them do their jobs, but the plethora of systems are also getting in the way.

The “never growing old” generation now faces retirement, a host of chronic health conditions, and mortality. The pandemic sparked a major shift toward digital channels to find health information, assess providers, and research Medicare plans and options.

Healthcare patients are evolving into consumers. This report examines the trends driving healthcare’s consumerization shift and discusses how incumbents can keep folks from going elsewhere by countering disruptors’ technology-centric strategies.

Telehealth is here to stay. It’s time for providers, payers, and vendors to give consumers what they want and make telehealth services a competitive advantage—or risk being left behind.

Investors and corporations are pouring billions of dollars into digital health companies with the goal of using solutions like telehealth, remote patient monitoring tools, and retail health clinics to reach consumers and deliver the care they need.

The global pandemic has had a profound impact on Generation Z’s well-being and is setting the stage for how they interact with and navigate the healthcare system.

The remote patient monitoring market is surging, with the number of US users doubling between 2020 and 2025. Consumers, healthcare providers, payers, and pharma companies are all investing in the technology and programs to improve care and lower cost.

The $300 billion primary care market is being disrupted by nontraditional players. This report examines how the primary care landscape has changed, who these disruptors are, and why their business models are shaking up the status quo.

Cyberattacks on healthcare providers are surging, putting more pressure on them to protect their systems from breaches.

Amazon is maneuvering to become a dominant player in direct-to-consumer healthcare services, beginning with its online pharmacy and telehealth services for its employees. It may acquire more healthcare delivery outlets, such as primary care and urgent care clinics. Entrenched industry players are watching carefully.

Interoperability has long been a pain point for the US healthcare system. While new federal regulations should spur payers and providers to adopt data-sharing solutions, ingrained information blocking practices, privacy concerns, and the demands of the pandemic may hamper efforts toward regulatory compliance.

This report explains the rise of tech-focused SDOH initiatives among US health insurers and hospitals, unpacks how these entities’ heavier focus on SDOH has ushered in opportunities for digital health vendors and tech companies operating at the periphery of healthcare to help address nonclinical health gaps, and lays out the factors driving the prioritization of SDOH and inhibiting these efforts’ growth.

In addition to building next-generation smart network infrastructure, 5G startups are piloting use cases across industries that take advantage of the performance advancements of 5G connections.

5G networks are operating in over 60 countries as of early 2021. This report reviews what the arrival of 5G means and focuses on some of the critical applications that will make it revolutionary.

5G will become one of the most promising technologies for facilitating healthcare’s digital transformation. This report analyzes five patient applications of 5G. It also explores forward-looking organizations embracing 5G and how healthcare organizations can follow in their footsteps.

The spread of the novel coronavirus across the US has driven the evolution of remote patient monitoring (RPM) solutions from nice-to-have to need-to-have. While there’s a rosy path ahead for RPM vendors, a number of roadblocks—like the connectivity divide and laggard doctors—may restrain RPM from reaching its full potential.

Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.